基本信息
浏览量:81
职业迁徙
个人简介
Ken Walder is the Chair of Metabolic Diseases in the School of Medicine and the Molecular and Medical Research SRC. His research focuses on obesity and type 2 diabetes, and mental health disorders, and in particular the discovery of novel treatments for these diseases. After spending two years at the National Institutes of Health, Phoenix, AZ, USA, he returned to Deakin University where he has played a key role in the evolution of the Metabolic Research Unit. He has authored more than 75 academic publications and is named as an inventor on more than 40 patent applications. He has worked closely with a number of industry partners, and is focused on conducting applied research with tangible outcomes that benefit Australia. In 2014, a compound discovered in his laboratory successfully completed a Phase 2 clinical trial for the treatment of type 2 diabetes.
研究兴趣
论文共 331 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Molecular psychiatryno. 8 (2024): 2487-2495
Neuropsychopharmacologyno. 6 (2024): 983-992
Nature communicationsno. 1 (2024)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 6 (2023): 5250-5250
The Lancet Psychiatryno. 4 (2023): 260-271
Alzheimer's & Dementiano. S2 (2023)
Neurotoxicity research/Neurotoxicity resarchno. 6 (2023): 502-513
CELL DEATH & DISEASEno. 12 (2023)
加载更多
作者统计
#Papers: 330
#Citation: 9708
H-Index: 45
G-Index: 85
Sociability: 7
Diversity: 0
Activity: 3
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn